Patient Information

Click on the buttons to turn on/off the filters.

Reset All
# Extranodal Site:
Performance Status (ECOG):
B Symptoms:
Testicular Involvement:
CNS Involvement:
Response to Initial Therapy:
MYC Expression:
BCL2 Expression:
ABC/GCB Classification:
This is a companion website to our study, Reddy, Zhang, Davis, Moffitt et al. The website is not designed for clinical decision-making.

Genetic Alterations

Survival Estimate

Data Set Sample Size 3-Year Survival Rate 0.95 Confidence Interval
Affected Patients 43 88.18 % [73.87%, 94.91%]
Remaining Patients 279 69.79 % [63.58%, 75.15%]
p-value: 0.066
Stage: I or II # Extranodal Site: 0 or 1 Testicular Involvement: Absent CNS Involvement: Absent BCL2 Expression: High